IONIS PHARMACEUT reported $4.17M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Astellas Pharma 4503:JP Y 58915M 10444M
Biocryst Pharmaceuticals BCRX:US $ 0.24M 0.18M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Exelixis EXEL:US $ 13.2M 0.29M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Moderna Inc MRNA:US 1.02B 65M
Nektar Therapeutics NKTR:US $ 6.16M 0.85M
Novartis NOVN:VX SF 3755M 245M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M